2018-2023 Global Hyperimmune Globulins Consumption Market Report

September 2018 | 166 pages | ID: 24FA9816D18EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Hyperimmune Globulins market for 2018-2023.

Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
In the last several years, global market of Hyperimmune Globulins developed rapidly, with an average growth rate of 6%. In 2017, global revenue of Hyperimmune Globulins is nearly 1150 million USD; the actual production is about 40 million units.
The classification includes the Hepatitis B Immunoglobulins, Rabies Immunoglobulins, Tetanus Immunoglobulins and others, and the proportion of Rabies Immunoglobulins in 2017 is about 44.2%, with the largest market share.
Hyperimmune Globulins is widely used in Government Institutions, Private Sector and Other. The most proportion of Hyperimmune Globulins is sold in Government Institutions, and the proportion in 2017 is about 62.7%.
Over the next five years, LPI(LP Information) projects that Hyperimmune Globulins will register a 9.7% CAGR in terms of revenue, reach US$ 1960 million by 2023, from US$ 1120 million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Hyperimmune Globulins market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Hepatitis B Immunoglobulins
• Rabies Immunoglobulins
• Tetanus Immunoglobulins
• Others

Segmentation by application:

• Government Institutions
• Private Sector
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• CSL Behring
• Grifols 
• Biotest
• Kedrion
• CBPO
• Emergent (Cangene)
• Kamada
• CNBG
• Hualan Bio
• Shanghai RAAS
• Sichuan Yuanda Shuyang
• ADMA Biologics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Hyperimmune Globulins consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Hyperimmune Globulins market by identifying its various subsegments.
• Focuses on the key global Hyperimmune Globulins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Hyperimmune Globulins with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Hyperimmune Globulins submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Hyperimmune Globulins Consumption 2013-2023
  2.1.2 Hyperimmune Globulins Consumption CAGR by Region
2.2 Hyperimmune Globulins Segment by Type
  2.2.1 Hepatitis B Immunoglobulins
  2.2.2 Rabies Immunoglobulins
  2.2.3 Tetanus Immunoglobulins
  2.2.4 Others
2.3 Hyperimmune Globulins Consumption by Type
  2.3.1 Global Hyperimmune Globulins Consumption Market Share by Type (2013-2018)
  2.3.2 Global Hyperimmune Globulins Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Hyperimmune Globulins Sale Price by Type (2013-2018)
2.4 Hyperimmune Globulins Segment by Application
  2.4.1 Government Institutions
  2.4.2 Private Sector
  2.4.3 Other
2.5 Hyperimmune Globulins Consumption by Application
  2.5.1 Global Hyperimmune Globulins Consumption Market Share by Application (2013-2018)
  2.5.2 Global Hyperimmune Globulins Value and Market Share by Application (2013-2018)
  2.5.3 Global Hyperimmune Globulins Sale Price by Application (2013-2018)

3 GLOBAL HYPERIMMUNE GLOBULINS BY PLAYERS

3.1 Global Hyperimmune Globulins Sales Market Share by Players
  3.1.1 Global Hyperimmune Globulins Sales by Players (2016-2018)
  3.1.2 Global Hyperimmune Globulins Sales Market Share by Players (2016-2018)
3.2 Global Hyperimmune Globulins Revenue Market Share by Players
  3.2.1 Global Hyperimmune Globulins Revenue by Players (2016-2018)
  3.2.2 Global Hyperimmune Globulins Revenue Market Share by Players (2016-2018)
3.3 Global Hyperimmune Globulins Sale Price by Players
3.4 Global Hyperimmune Globulins Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Hyperimmune Globulins Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Hyperimmune Globulins Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 HYPERIMMUNE GLOBULINS BY REGIONS

4.1 Hyperimmune Globulins by Regions
  4.1.1 Global Hyperimmune Globulins Consumption by Regions
  4.1.2 Global Hyperimmune Globulins Value by Regions
4.2 Americas Hyperimmune Globulins Consumption Growth
4.3 APAC Hyperimmune Globulins Consumption Growth
4.4 Europe Hyperimmune Globulins Consumption Growth
4.5 Middle East & Africa Hyperimmune Globulins Consumption Growth

5 AMERICAS

5.1 Americas Hyperimmune Globulins Consumption by Countries
  5.1.1 Americas Hyperimmune Globulins Consumption by Countries (2013-2018)
  5.1.2 Americas Hyperimmune Globulins Value by Countries (2013-2018)
5.2 Americas Hyperimmune Globulins Consumption by Type
5.3 Americas Hyperimmune Globulins Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Hyperimmune Globulins Consumption by Countries
  6.1.1 APAC Hyperimmune Globulins Consumption by Countries (2013-2018)
  6.1.2 APAC Hyperimmune Globulins Value by Countries (2013-2018)
6.2 APAC Hyperimmune Globulins Consumption by Type
6.3 APAC Hyperimmune Globulins Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Hyperimmune Globulins by Countries
  7.1.1 Europe Hyperimmune Globulins Consumption by Countries (2013-2018)
  7.1.2 Europe Hyperimmune Globulins Value by Countries (2013-2018)
7.2 Europe Hyperimmune Globulins Consumption by Type
7.3 Europe Hyperimmune Globulins Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Hyperimmune Globulins by Countries
  8.1.1 Middle East & Africa Hyperimmune Globulins Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Hyperimmune Globulins Value by Countries (2013-2018)
8.2 Middle East & Africa Hyperimmune Globulins Consumption by Type
8.3 Middle East & Africa Hyperimmune Globulins Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Hyperimmune Globulins Distributors
10.3 Hyperimmune Globulins Customer

11 GLOBAL HYPERIMMUNE GLOBULINS MARKET FORECAST

11.1 Global Hyperimmune Globulins Consumption Forecast (2018-2023)
11.2 Global Hyperimmune Globulins Forecast by Regions
  11.2.1 Global Hyperimmune Globulins Forecast by Regions (2018-2023)
  11.2.2 Global Hyperimmune Globulins Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Hyperimmune Globulins Forecast by Type
11.8 Global Hyperimmune Globulins Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 CSL Behring
  12.1.1 Company Details
  12.1.2 Hyperimmune Globulins Product Offered
  12.1.3 CSL Behring Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 CSL Behring News
12.2 Grifols
  12.2.1 Company Details
  12.2.2 Hyperimmune Globulins Product Offered
  12.2.3 Grifols Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Grifols News
12.3 Biotest
  12.3.1 Company Details
  12.3.2 Hyperimmune Globulins Product Offered
  12.3.3 Biotest Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Biotest News
12.4 Kedrion
  12.4.1 Company Details
  12.4.2 Hyperimmune Globulins Product Offered
  12.4.3 Kedrion Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Kedrion News
12.5 CBPO
  12.5.1 Company Details
  12.5.2 Hyperimmune Globulins Product Offered
  12.5.3 CBPO Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 CBPO News
12.6 Emergent (Cangene)
  12.6.1 Company Details
  12.6.2 Hyperimmune Globulins Product Offered
  12.6.3 Emergent (Cangene) Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Emergent (Cangene) News
12.7 Kamada
  12.7.1 Company Details
  12.7.2 Hyperimmune Globulins Product Offered
  12.7.3 Kamada Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Kamada News
12.8 CNBG
  12.8.1 Company Details
  12.8.2 Hyperimmune Globulins Product Offered
  12.8.3 CNBG Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 CNBG News
12.9 Hualan Bio
  12.9.1 Company Details
  12.9.2 Hyperimmune Globulins Product Offered
  12.9.3 Hualan Bio Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Hualan Bio News
12.10 Shanghai RAAS
  12.10.1 Company Details
  12.10.2 Hyperimmune Globulins Product Offered
  12.10.3 Shanghai RAAS Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Shanghai RAAS News
12.11 Sichuan Yuanda Shuyang
12.12 ADMA Biologics

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Hyperimmune Globulins
Table Product Specifications of Hyperimmune Globulins
Figure Hyperimmune Globulins Report Years Considered
Figure Market Research Methodology
Figure Global Hyperimmune Globulins Consumption Growth Rate 2013-2023 (K Units)
Figure Global Hyperimmune Globulins Value Growth Rate 2013-2023 ($ Millions)
Table Hyperimmune Globulins Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Hepatitis B Immunoglobulins
Table Major Players of Hepatitis B Immunoglobulins
Figure Product Picture of Rabies Immunoglobulins
Table Major Players of Rabies Immunoglobulins
Figure Product Picture of Tetanus Immunoglobulins
Table Major Players of Tetanus Immunoglobulins
Figure Product Picture of Others
Table Major Players of Others
Table Global Consumption Sales by Type (2013-2018)
Table Global Hyperimmune Globulins Consumption Market Share by Type (2013-2018)
Figure Global Hyperimmune Globulins Consumption Market Share by Type (2013-2018)
Table Global Hyperimmune Globulins Revenue by Type (2013-2018) ($ million)
Table Global Hyperimmune Globulins Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Hyperimmune Globulins Value Market Share by Type (2013-2018)
Table Global Hyperimmune Globulins Sale Price by Type (2013-2018)
Figure Hyperimmune Globulins Consumed in Government Institutions
Figure Global Hyperimmune Globulins Market: Government Institutions (2013-2018) (K Units)
Figure Global Hyperimmune Globulins Market: Government Institutions (2013-2018) ($ Millions)
Figure Global Government Institutions YoY Growth ($ Millions)
Figure Hyperimmune Globulins Consumed in Private Sector
Figure Global Hyperimmune Globulins Market: Private Sector (2013-2018) (K Units)
Figure Global Hyperimmune Globulins Market: Private Sector (2013-2018) ($ Millions)
Figure Global Private Sector YoY Growth ($ Millions)
Figure Hyperimmune Globulins Consumed in Other
Figure Global Hyperimmune Globulins Market: Other (2013-2018) (K Units)
Figure Global Hyperimmune Globulins Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Hyperimmune Globulins Consumption Market Share by Application (2013-2018)
Figure Global Hyperimmune Globulins Consumption Market Share by Application (2013-2018)
Table Global Hyperimmune Globulins Value by Application (2013-2018)
Table Global Hyperimmune Globulins Value Market Share by Application (2013-2018)
Figure Global Hyperimmune Globulins Value Market Share by Application (2013-2018)
Table Global Hyperimmune Globulins Sale Price by Application (2013-2018)
Table Global Hyperimmune Globulins Sales by Players (2016-2018) (K Units)
Table Global Hyperimmune Globulins Sales Market Share by Players (2016-2018)
Figure Global Hyperimmune Globulins Sales Market Share by Players in 2016
Figure Global Hyperimmune Globulins Sales Market Share by Players in 2017
Table Global Hyperimmune Globulins Revenue by Players (2016-2018) ($ Millions)
Table Global Hyperimmune Globulins Revenue Market Share by Players (2016-2018)
Figure Global Hyperimmune Globulins Revenue Market Share by Players in 2016
Figure Global Hyperimmune Globulins Revenue Market Share by Players in 2017
Table Global Hyperimmune Globulins Sale Price by Players (2016-2018)
Figure Global Hyperimmune Globulins Sale Price by Players in 2017
Table Global Hyperimmune Globulins Manufacturing Base Distribution and Sales Area by Players
Table Players Hyperimmune Globulins Products Offered
Table Hyperimmune Globulins Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Hyperimmune Globulins Consumption by Regions 2013-2018 (K Units)
Table Global Hyperimmune Globulins Consumption Market Share by Regions 2013-2018
Figure Global Hyperimmune Globulins Consumption Market Share by Regions 2013-2018
Table Global Hyperimmune Globulins Value by Regions 2013-2018 ($ Millions)
Table Global Hyperimmune Globulins Value Market Share by Regions 2013-2018
Figure Global Hyperimmune Globulins Value Market Share by Regions 2013-2018
Figure Americas Hyperimmune Globulins Consumption 2013-2018 (K Units)
Figure Americas Hyperimmune Globulins Value 2013-2018 ($ Millions)
Figure APAC Hyperimmune Globulins Consumption 2013-2018 (K Units)
Figure APAC Hyperimmune Globulins Value 2013-2018 ($ Millions)
Figure Europe Hyperimmune Globulins Consumption 2013-2018 (K Units)
Figure Europe Hyperimmune Globulins Value 2013-2018 ($ Millions)
Figure Middle East & Africa Hyperimmune Globulins Consumption 2013-2018 (K Units)
Figure Middle East & Africa Hyperimmune Globulins Value 2013-2018 ($ Millions)
Table Americas Hyperimmune Globulins Consumption by Countries (2013-2018) (K Units)
Table Americas Hyperimmune Globulins Consumption Market Share by Countries (2013-2018)
Figure Americas Hyperimmune Globulins Consumption Market Share by Countries in 2017
Table Americas Hyperimmune Globulins Value by Countries (2013-2018) ($ Millions)
Table Americas Hyperimmune Globulins Value Market Share by Countries (2013-2018)
Figure Americas Hyperimmune Globulins Value Market Share by Countries in 2017
Table Americas Hyperimmune Globulins Consumption by Type (2013-2018) (K Units)
Table Americas Hyperimmune Globulins Consumption Market Share by Type (2013-2018)
Figure Americas Hyperimmune Globulins Consumption Market Share by Type in 2017
Table Americas Hyperimmune Globulins Consumption by Application (2013-2018) (K Units)
Table Americas Hyperimmune Globulins Consumption Market Share by Application (2013-2018)
Figure Americas Hyperimmune Globulins Consumption Market Share by Application in 2017
Figure United States Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure United States Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Canada Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Canada Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Mexico Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Mexico Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Table APAC Hyperimmune Globulins Consumption by Countries (2013-2018) (K Units)
Table APAC Hyperimmune Globulins Consumption Market Share by Countries (2013-2018)
Figure APAC Hyperimmune Globulins Consumption Market Share by Countries in 2017
Table APAC Hyperimmune Globulins Value by Countries (2013-2018) ($ Millions)
Table APAC Hyperimmune Globulins Value Market Share by Countries (2013-2018)
Figure APAC Hyperimmune Globulins Value Market Share by Countries in 2017
Table APAC Hyperimmune Globulins Consumption by Type (2013-2018) (K Units)
Table APAC Hyperimmune Globulins Consumption Market Share by Type (2013-2018)
Figure APAC Hyperimmune Globulins Consumption Market Share by Type in 2017
Table APAC Hyperimmune Globulins Consumption by Application (2013-2018) (K Units)
Table APAC Hyperimmune Globulins Consumption Market Share by Application (2013-2018)
Figure APAC Hyperimmune Globulins Consumption Market Share by Application in 2017
Figure China Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure China Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Japan Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Japan Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Korea Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Korea Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure India Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure India Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Australia Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Australia Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Table Europe Hyperimmune Globulins Consumption by Countries (2013-2018) (K Units)
Table Europe Hyperimmune Globulins Consumption Market Share by Countries (2013-2018)
Figure Europe Hyperimmune Globulins Consumption Market Share by Countries in 2017
Table Europe Hyperimmune Globulins Value by Countries (2013-2018) ($ Millions)
Table Europe Hyperimmune Globulins Value Market Share by Countries (2013-2018)
Figure Europe Hyperimmune Globulins Value Market Share by Countries in 2017
Table Europe Hyperimmune Globulins Consumption by Type (2013-2018) (K Units)
Table Europe Hyperimmune Globulins Consumption Market Share by Type (2013-2018)
Figure Europe Hyperimmune Globulins Consumption Market Share by Type in 2017
Table Europe Hyperimmune Globulins Consumption by Application (2013-2018) (K Units)
Table Europe Hyperimmune Globulins Consumption Market Share by Application (2013-2018)
Figure Europe Hyperimmune Globulins Consumption Market Share by Application in 2017
Figure Germany Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Germany Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure France Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure France Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure UK Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure UK Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Italy Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Italy Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Russia Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Russia Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Spain Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Spain Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Hyperimmune Globulins Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Hyperimmune Globulins Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Hyperimmune Globulins Consumption Market Share by Countries in 2017
Table Middle East & Africa Hyperimmune Globulins Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Hyperimmune Globulins Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Hyperimmune Globulins Value Market Share by Countries in 2017
Table Middle East & Africa Hyperimmune Globulins Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Hyperimmune Globulins Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Hyperimmune Globulins Consumption Market Share by Type in 2017
Table Middle East & Africa Hyperimmune Globulins Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Hyperimmune Globulins Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Hyperimmune Globulins Consumption Market Share by Application in 2017
Figure Egypt Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Egypt Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure South Africa Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure South Africa Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Israel Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Israel Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure Turkey Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure Turkey Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Hyperimmune Globulins Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Hyperimmune Globulins Value Growth 2013-2018 ($ Millions)
Table Hyperimmune Globulins Distributors List
Table Hyperimmune Globulins Customer List
Figure Global Hyperimmune Globulins Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Hyperimmune Globulins Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Hyperimmune Globulins Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Hyperimmune Globulins Consumption Market Forecast by Regions
Table Global Hyperimmune Globulins Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Hyperimmune Globulins Value Market Share Forecast by Regions
Figure Americas Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Americas Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure APAC Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure APAC Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Europe Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Europe Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Middle East & Africa Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Middle East & Africa Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure United States Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure United States Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Canada Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Canada Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Mexico Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Mexico Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Brazil Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Brazil Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure China Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure China Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Japan Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Japan Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Korea Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Korea Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Southeast Asia Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Southeast Asia Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure India Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure India Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Australia Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Australia Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Germany Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Germany Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure France Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure France Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure UK Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure UK Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Italy Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Italy Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Russia Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Russia Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Spain Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Spain Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Egypt Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Egypt Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure South Africa Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure South Africa Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Israel Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Israel Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure Turkey Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure Turkey Hyperimmune Globulins Value 2018-2023 ($ Millions)
Figure GCC Countries Hyperimmune Globulins Consumption 2018-2023 (K Units)
Figure GCC Countries Hyperimmune Globulins Value 2018-2023 ($ Millions)
Table Global Hyperimmune Globulins Consumption Forecast by Type (2018-2023) (K Units)
Table Global Hyperimmune Globulins Consumption Market Share Forecast by Type (2018-2023)
Table Global Hyperimmune Globulins Value Forecast by Type (2018-2023) ($ Millions)
Table Global Hyperimmune Globulins Value Market Share Forecast by Type (2018-2023)
Table Global Hyperimmune Globulins Consumption Forecast by Application (2018-2023) (K Units)
Table Global Hyperimmune Globulins Consumption Market Share Forecast by Application (2018-2023)
Table Global Hyperimmune Globulins Value Forecast by Application (2018-2023) ($ Millions)
Table Global Hyperimmune Globulins Value Market Share Forecast by Application (2018-2023)
Table CSL Behring Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CSL Behring Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CSL Behring Hyperimmune Globulins Market Share (2016-2018)
Table Grifols Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Grifols Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Grifols Hyperimmune Globulins Market Share (2016-2018)
Table Biotest Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biotest Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biotest Hyperimmune Globulins Market Share (2016-2018)
Table Kedrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kedrion Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Kedrion Hyperimmune Globulins Market Share (2016-2018)
Table CBPO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CBPO Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CBPO Hyperimmune Globulins Market Share (2016-2018)
Table Emergent (Cangene) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emergent (Cangene) Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Emergent (Cangene) Hyperimmune Globulins Market Share (2016-2018)
Table Kamada Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kamada Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Kamada Hyperimmune Globulins Market Share (2016-2018)
Table CNBG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CNBG Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure CNBG Hyperimmune Globulins Market Share (2016-2018)
Table Hualan Bio Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Bio Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hualan Bio Hyperimmune Globulins Market Share (2016-2018)
Table Shanghai RAAS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shanghai RAAS Hyperimmune Globulins Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Shanghai RAAS Hyperimmune Globulins Market Share (2016-2018)
Table Sichuan Yuanda Shuyang Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ADMA Biologics Basic Information, Manufacturing Base, Sales Area and Its Competitors